Manila Bulletin
DOST’s expert panel to look into more data on use of Sinovac vaccine on senior citizens
The Vaccine Expert Panel (VEP) continues to review data from other countries regarding the use of Sinovac's CoronaVac vaccine on senior citizens.
VEP chairperson Dr. Nina Gloriani stated that the vaccine has a "good safety profile" and can protect seniors against severe COVID-19.
She mentioned that they are examining efficacy data in different age groups, including information from Chile on individuals over 70 years old, to understand real-world conditions.
The VEP had previously recommended Sinovac for those aged 60 and above due to a shortage of AstraZeneca vaccines.
The Food and Drug Administration (FDA) has since approved Sinovac for senior citizens.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippine Food and Drug Administration (FDA) has approved the use of the Sinovac COVID-19 vaccine for senior citizens, with simultaneous vaccination set to begin on April 12.
+2
Read more →
San Juan City has started its vaccination program for senior citizens using Sinovac Biotech's CoronaVac vaccines, following FDA approval for individuals aged 60 and above.
Read more →
The Manila city government began inoculating its senior citizens with the Sinovac COVID-19 vaccine on Thursday, April 8, 2021.
Read more →
The oldest resident of Las Piñas City, 101-year-old Tomasa Amurao, received the AstraZeneca COVID-19 vaccine.
Read more →
The Philippines has temporarily suspended the use of AstraZeneca's COVID-19 vaccine for individuals under 60 years old as a precautionary measure due to rare reports of blood clots with low platelet counts overseas, primarily observed in women under 60.
+2
Read more →